Trying to figure why the BOD would give away max shares to management with no results. Like some parting gift or let's wrap it up boys game over. The options hand out compared to results was ridiculous.
Howson and Driscoll both picking up new director gigs. HMMM
Driscoll like 63 and FLEXION right in the middle of a major drug manufacturing undertaken. A CFO would seemingly be quite busy in that kind of ramp up. I think he is either retiring or moving out of FLEXION and maybe Oxigene too. Cramming Pedder to the board is peculiar in that it needed to happen right now.
Like big news happening real soon. Howson, Driscoll both leaving? Company going private?
Take over? Driscolls way of #$%$ on shareholders one last time? Give away 30 percent and walk out the door. I hope those attending the meeting expect some accountability.
Always xpect d unxpect
I expected ccs after each of the last e earnings releases
I expected a and z and a p3 blessed by the fda after the gog 186i data
basherbustterr • Mar 14, 2016 11:51 AM
Devastating earnings as there is almost no cash left on top of what is expected failure report
of phase 3. Where this stock price will end up ?
floirdahockeyman • Mar 11, 2016 12:21 PM
LLets close today in deep red as past 3 weeks we did...lets join the party...lol
Those who will join the party in this Death Spiral Slide will ultimately get rewarded big time as stock is predicted to go under $.05 when the news will hit the air.......I will make high 7 figures by then....$$$$$$$$$$$$$$$$$$$$$$$$$$$ to all!
Who does that sound like..ya.
I posted all of that this week. Go find it. I posted many times that they need to choose one or the other to develop, and that OXi4503 should be monetized/sold in order to do that. You don't know what you're looking at. Even if you did, you'd lie about it the next day. Think about the exceptional. Expect the unexpected. EOS.
Did any of you girl scouts notice that Celator is now worth $750M based total on DATA from two reformulated generic chemos. $50M to $750M. Data cxukers. Data. Did I mention the data?
If u said that i stand corrected.I did look up your last month or so of posts and did not see it.How did you vote on rs and options?All of us with so called agendas think the drug works.Posting drug sale estimates maybe good for shareholders in 18 months or 2 years but not when we are looking down the barrel of a 3rd rs and exec options next year off the charts and a 66c pps.I did put u on our mb bod for a reason